Literature DB >> 20628110

Development of encapsulating peritoneal sclerosis in a renal transplant recipient on sirolimus immunotherapy.

S Temple, J Zaltzman, J Perl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628110     DOI: 10.3747/pdi.2009.00211

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  5 in total

1.  Encapsulating Peritoneal Sclerosis In a Kidney Graft Recipient Unmasked by Everolimus Switch.

Authors:  Agnieszka A Pozdzik; Vasco Fernandez; Pieter Demetter; Monika Tooulou; Celso Matos; Nadia Gammar; Nilufer Broeders; Max Dratwa; Joëlle Nortier
Journal:  Perit Dial Int       Date:  2015-12       Impact factor: 1.756

2.  mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: a favourable single center experience.

Authors:  Maria Messina; Claudia Ariaudo; Alberto Mella; Vincenzo Cantaluppi; Giuseppe P Segoloni; Luigi Biancone
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

3.  Comparison of sirolimus and colchicine treatment on the development of peritoneal fibrozis in rats having peritoneal dialysis.

Authors:  Tamer Sağıroğlu; Mustafa Burak Sayhan; Mehmet A Yağcı; Tülin Yalta; Gönül Sağıroğlu; Elif Çopuroğlu; Serhat Oğuz
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

4.  Post-transplantation encapsulating peritoneal sclerosis in a pediatric patient.

Authors:  Nicole da Silva; Sofia Rocha; Liliana Rocha; Sameiro Faria; Teresa Costa; Conceição Mota
Journal:  Pediatr Nephrol       Date:  2012-04-24       Impact factor: 3.714

Review 5.  Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.

Authors:  Rajesh M Jagirdar; Andreas Bozikas; Sotirios G Zarogiannis; Maria Bartosova; Claus Peter Schmitt; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.